RBDCOV Talks
Episodes
Lessons Learned: insights, learnings, and takeaways.
26 Aug 2025
Contributed by Lukas
As RBDCOV nears its end, what have we truly learned? 📚 Laura Ferrer from HIPRA reflects on the key takeaways, lessons, and insights gained througho...
The Psychosocial Perspective: what participants teach us.
26 Aug 2025
Contributed by Lukas
💬 What motivated participants to join? How did they experience the process? And what lessons can we learn from their stories? Join Daniela Rojas Ca...
It Starts and Ends With Us: Community at the Centre of Research.
26 Aug 2025
Contributed by Lukas
How the community engagement campaign was built and why inclusion and diversity in clinical research are more than buzzwords they’re essential for i...
Trial results: what are they main findings and what’s next?
21 Nov 2023
Contributed by Lukas
Why is data so crucial? Is it only significant for the scientific community? Let's address the importance of collaboration and data sharing for a heal...
What will the direct contribution of RBDCOV be if both clinical trials are proven to be effective?
21 Nov 2023
Contributed by Lukas
In this episode, we decode RBDCOV's direct contribution. What if both trials succeed? Let's understand the potential impact on global health with Dr. ...
Where are we with COVID-19 and what does the future hold?
21 Nov 2023
Contributed by Lukas
Considering how changing the COVID situation is, let's understand where we are with COVID-19 and what the future holds with Dr. Mete Tam from METPHARM...
All about personalised vaccines: what are they and what is their future?
21 Nov 2023
Contributed by Lukas
Delves into personalized vaccines. What makes them unique, and what does the future hold for customized immunization? Uncover its potential with Julia...
Why should people living with HIV and other immunocompromising conditions be included in clinical trials similar to the RBDCOV trial?
21 Nov 2023
Contributed by Lukas
Shed light on immunocompromised clinical trials inclusion. 🦠 Why involve those with HIV? Join our conversation with Juanfran C and Arda from EATG t...
Why have paediatric and adolescent participants been included in this trial?
21 Nov 2023
Contributed by Lukas
Explore the significance of including the youngest in vaccine trials with Pablo Rojo from PENTA. Join us as we discuss the impact on child health and ...
All about immunological memory: what is it, how is it obtained and what is the result?
21 Nov 2023
Contributed by Lukas
Unveil the vital role of immunological memory, the key to long-lasting, protective immunity with Pere Soler Palacin from Vall D'Hebron. Understand why...
All about vaccine clinical trials: what are they and how do they work?
21 Nov 2023
Contributed by Lukas
Explore the intricate world of vaccine clinical trials with Montse Barceló from VERISTAT. 🧪 What are they, and how do they shape the future of hea...
What’s Drug Safety? What is Drug Safety-level safety monitoring like in vaccine clinical trials?
21 Nov 2023
Contributed by Lukas
Discover the critical role of Drug Safety in vaccine trials with Helena Belinchon from ASPHALION. 🩺 How do experts ensure safety at every level? Jo...
In 5 minutes, what is a recombinant protein vaccine?
21 Nov 2023
Contributed by Lukas
🧬Dive into the world of recombinant protein vaccines in just 10 minutes with Antonio Barreiro from HIPRA. Unveil the science behind this innovative...